Triglyceride-lowering effect of a novel insulin-sensitizing agent, JTT-501

European Journal of Pharmacology

Volumn 373, Issue 1, 1999, Pages 85-91

  Shibata, Tsutomu ^a   Matsui, Kenichi ^a   Yonemori, Fumihiko ^a   Wakitani, Korekiyo ^a  

^a Central Pharmaceutical Research Institute   (Japan)

Author keywords

Insulin sensitizing agent; JTT 501; Triglyceride

Indexed keywords

GLUCOSE; INSULIN; ISOXAZOLIDINE DERIVATIVE; PIOGLITAZONE; REGLITAZAR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE OXIDATION; HALF LIFE TIME; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID METABOLISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; BODY WEIGHT; DIETARY FATS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; ISOXAZOLES; MALE; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLES; THIAZOLIDINEDIONES; TRIGLYCERIDES;

EID: 0032980841     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00256-3     Document Type: Article

References (27)

1. Abbate S.L., Brunzell J.D. Pathophysiology of hyperlipidemia in diabetes mellitus. J. Cardiol. Pharmacol. 16:1990;S1-S7. Suppl. 9.
2. Braissant O., Foufelle F., Scotto C., Dauça M., Wahli W. Differential expression of peroxisome proliferator-activated receptor (PPARs): tissue distribution of PPAR-α, -β, -γ in the adult rat. Endocrinology. 137:1996;354-366.
3. Desvergne B., Ijpenberg A., Devchand P.R., Wahli W. The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signaling. J. Steroid Biochem. Mol. Biol. 65:1998;65-74.
4. Eckel R.H. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. New Engl. J. Med. 320:1989;1060-1068.
5. Feingold K.R., Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes. 41:1992;97-101. Suppl. 2.
6. Gordon D.A., Wetterau J.R., Gregg R.E. Microsomal triglyceride transfer protein: a protein complex required for the assembly of lipoprotein particles. Trends Cell Biol. 5:1995;317-321.
7. Iritani N., Hosomi H., Fukuda H., Ikeda H. Polyunsaturated fatty acid regulation of lipogenic enzyme gene expression in liver of genetically obese rat. Biochem. Biophys. Acta. 1255:1995;1-8.
8. Iwanishi M., Kobayashi M. Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats. Metabolism. 42:1993;1017-1021.
9. Keller H., Dreyer C., Medin J., Mahfoudi A., Ozato K., Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA. 90:1993;2160-2164.
10. Knudsen P., Eriksson J., Lahdenperä S., Kahri J., Groop L., Taskinen M.R. The Botnia study group, changes of lipolytic enzymes cluster with insulin resistance syndrome. Diabetologia. 38:1995;344-350.
11. Maegawa H., Kobayashi M., Ishibashi O., Takata Y., Shigeta Y. Effect of diet change on insulin action: difference between muscles and adipocytes. Am. J. Physiol. 251:1986;E616-E623.
12. Maegawa H., Obata T., Shibata T., Fujita T., Ugi S., Morino K., Nishio Y., Kojima H., Hidaka H., Haneda M., Yasuda H., Kikkawa R., Kashiwagi A. A new antidiabetic agent (JTT-501) rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle. Diabetologia. 42:1999;151-159.
13. Pfeifer M.A., Brunzell J.D., Best J.D., Judzewitsch R.G., Halter J.B., Porte D. Jr. The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia. Diabetes. 32:1983;525-531.
14. Robinson C.E., Wu X., Morris D.C., Gimble J.M. DNA bending is induced by binding of the peroxisome proliferator-activated receptor γ2 heterodimer to its response element in the murine lipoprotein lipase promoter. Biochem. Biophys. Res. Commun. 244:1998;671-677.
15. Sadur C.N., Eckel R.H. Insulin stimulation of adipose tissue lipoprotein lipase: use of the euglycemic clamp technique. J. Clin. Invest. 69:1982;1119-1125.
16. Saltiel A.R., Olefsky J.M. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes. 45:1996;1661-1669.
17. Schoonjans K., Staels B., Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37:1996;907-925.
18. Shibata T., Matsui K., Yonemori F., Wakitani K. JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models. Br. J. Pharmacol. 125:1998;1744-1750.
19. Shibata T., Matsui K., Nagao K., Shinkai H., Yonemori F., Wakitani K. Pharmacological profiles of a novel antidiabetic agent, JTT-501, an isoxazolidinedione derivative. Eur. J. Pharmacol. 364:1999;211-219.
20. Shinkai H., Onogi S., Tanaka M., Shibata T., Iwao M., Wakitani K., Uchida I. Isoxazolidine-3,5-dione and noncyclic 1,3-dicarbonyl compounds as hypoglycemic agents. J. Med. Chem. 41:1998;1927-1933.
21. Sparks J.D., Sparks C.E. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochem. Biophys. Acta. 1215:1994;9-32.
22. Steiner G., Lewis G.F. Hyperinsulinemia and triglyceride-rich lipoproteins. Diabetes. 45:1996;S24-S26. Suppl. 3.
23. Storlien L.H., Baur L.A., Kriketos A.D., Pan D.A., Cooney G.J., Jenkins A.B., Calvert G.D., Campbell L.V. Dietary fats and insulin action. Diabetologia. 39:1996;621-631.
24. Sugiyama Y., Shimura Y., Ikeda H. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats. Arzneim.-Forsch./Drug Res. 40:1990;263-267.
25. Terasaki J., Anai M., Funaki M., Shibata T., Inukai K., Ogihara T., Ishihara H., Katagiri H., Onishi Y., Sakoda H., Fukushima Y., Yazaki Y., Kikuchi M., Oka Y., Asano T. Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat diet. Diabetologia. 41:1998;400-409.
26. Yamazaki Y., Murakami T., Osaka T., Iino S., Mizushima Y., Inoue S. The effect of JTT-501 on serum triglycerides in obese Zucker fatty rats. Diabetologia. 40:1997;A415. Suppl. 1.
27. Yost T.J., Sadur C.N., Eckel R.H. Glycohemoglobin levels relate to the response of adipose tissue lipoprotein lipase to insulin/glucose in obese non-insulin-dependent diabetes mellitus. Metabolism. 44:1995;1475-1480.